A Case of Successful Treatment of Small Cell Carcinoma of the Bladder with Pembrolizumab
Small cell carcinoma of the bladder (SCCB) is a rare cancer that accounts for approximately 1% of primary malignant bladder tumors. It is highly malignant and has a poor prognosis. Similar to small cell lung cancer, platinum-based chemotherapy is recommended as the first-line therapy, and amrubicin...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 70(2024), 4 vom: 12. Apr., Seite 93-99
|
1. Verfasser: |
Aigase, Tomohiko
(VerfasserIn) |
Weitere Verfasser: |
Tatenuma, Tomoyuki,
Uemura, Koichi,
Makiyama, Kazuhide,
Kobayashi, Noritoshi,
Kato, Ikuma,
Yamanaka, Shoji,
Fujii, Seiji |
Format: | Online-Aufsatz
|
Sprache: | Japanese |
Veröffentlicht: |
2024
|
Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
Schlagworte: | Case Reports
Journal Article
English Abstract
pembrolizumab
DPT0O3T46P
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological |